Allison AC, Almquist SJ, Muller CD, Eugui EM (1991) In vitro immunosuppressive effects of mycophenolic acid and an ester pro-drug, RS-61443. Transplant Proc 23:10–14
Allison AC, Eugui EM (1993) The design and development of an immunosuppressive drug, mycophenolate mofetil. Springer Semin Immunopathol 14:353–380. https://doi.org/10.1007/BF00192309
Article CAS PubMed Google Scholar
Allison AC, Eugui EM (2000) Mycophenolate mofetil and its mechanisms of action. Immunopharmacology 47:85–118. https://doi.org/10.1016/s0162-3109(00)00188-0
Article CAS PubMed Google Scholar
Allison AC, Hovi T, Watts RW, Webster AD (1975) Immunological observations on patients with Lesch-Nyhan syndrome, and on the role of de-novo purine synthesis in lymphocyte transformation. Lancet 2:1179–1183. https://doi.org/10.1016/s0140-6736(75)92661-6
Article CAS PubMed Google Scholar
Anastas JN, Zee BM, Kalin JH, Kim M, Guo R, Alexandrescu S et al (2019) Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG. Cancer Cell 36(528–44):e10. https://doi.org/10.1016/j.ccell.2019.09.005
Aoki Y, Hashizume R, Ozawa T, Banerjee A, Prados M, James CD et al (2012) An experimental xenograft mouse model of diffuse pontine glioma designed for therapeutic testing. J Neurooncol 108:29–35. https://doi.org/10.1007/s11060-011-0796-x
Barfeld SJ, Fazli L, Persson M, Marjavaara L, Urbanucci A, Kaukoniemi KM et al (2015) Myc-dependent purine biosynthesis affects nucleolar stress and therapy response in prostate cancer. Oncotarget 6:12587–12602. https://doi.org/10.18632/oncotarget.3494
Article PubMed PubMed Central Google Scholar
Barsotti C, Pesi R, Giannecchini M, Ipata PL (2005) Evidence for the involvement of cytosolic 5′-nucleotidase (cN-II) in the synthesis of guanine nucleotides from xanthosine. J Biol Chem 280:13465–13469. https://doi.org/10.1074/jbc.M413347200
Article CAS PubMed Google Scholar
Barton KL, Misuraca K, Cordero F, Dobrikova E, Min HD, Gromeier M et al (2013) PD-0332991, a CDK4/6 inhibitor, significantly prolongs survival in a genetically engineered mouse model of brainstem glioma. PLoS One 8:e77639. https://doi.org/10.1371/journal.pone.0077639
Article CAS PubMed PubMed Central Google Scholar
Benjanuwattra J, Chaiyawat P, Pruksakorn D, Koonrungsesomboon N (2020) Therapeutic potential and molecular mechanisms of mycophenolic acid as an anticancer agent. Eur J Pharmacol 887:173580. https://doi.org/10.1016/j.ejphar.2020.173580
Article CAS PubMed Google Scholar
Carr SF, Papp E, Wu JC, Natsumeda Y (1993) Characterization of human type I and type II IMP dehydrogenases. J Biol Chem 268:27286–27290
Chen B, Ma L, Paik H, Sirota M, Wei W, Chua MS et al (2017) Reversal of cancer gene expression correlates with drug efficacy and reveals therapeutic targets. Nat Commun 8:16022. https://doi.org/10.1038/ncomms16022
Article CAS PubMed PubMed Central Google Scholar
Chen B, Wei W, Ma L, Yang B, Gill RM, Chua MS et al (2017) Computational discovery of niclosamide ethanolamine, a repurposed drug candidate that reduces growth of hepatocellular carcinoma cells in vitro and in mice by inhibiting cell division cycle 37 signaling. Gastroenterology 152:2022–2036. https://doi.org/10.1053/j.gastro.2017.02.039
Article CAS PubMed Google Scholar
Chen EY, Tan CM, Kou Y, Duan Q, Wang Z, Meirelles GV et al (2013) Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool. BMC Bioinform 14:128. https://doi.org/10.1186/1471-2105-14-128
Chen Y, Sun L, Xu H, Dong M, Mizuno T, Vinks AA et al (2020) PK/PD Study of mycophenolate mofetil in children with systemic lupus erythematosus to inform model-based precision dosing. Front Pharmacol 11:605060. https://doi.org/10.3389/fphar.2020.605060
Article CAS PubMed PubMed Central Google Scholar
Chong YC, Toh TB, Chan Z, Lin QXX, Thng DKH, Hooi L et al (2020) Targeted inhibition of purine metabolism is effective in suppressing hepatocellular carcinoma progression. Hepatol Commun 4:1362–1381. https://doi.org/10.1002/hep4.1559
Article CAS PubMed PubMed Central Google Scholar
Cohen KJ, Jabado N, Grill J (2017) Diffuse intrinsic pontine gliomas-current management and new biologic insights. Is there a glimmer of hope? Neuro Oncol 19:1025–1034. https://doi.org/10.1093/neuonc/nox021
Article CAS PubMed PubMed Central Google Scholar
Corsello SM, Bittker JA, Liu Z, Gould J, McCarren P, Hirschman JE et al (2017) The drug repurposing hub: a next-generation drug library and information resource. Nat Med 23:405–408. https://doi.org/10.1038/nm.4306
Article CAS PubMed PubMed Central Google Scholar
DeWire M, Fuller C, Hummel TR, Chow LML, Salloum R, de Blank P et al (2020) A phase I/II study of ribociclib following radiation therapy in children with newly diagnosed diffuse intrinsic pontine glioma (DIPG). J Neurooncol 149:511–522. https://doi.org/10.1007/s11060-020-03641-2
Article CAS PubMed Google Scholar
Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S et al (2013) STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29:15–21. https://doi.org/10.1093/bioinformatics/bts635
Article CAS PubMed Google Scholar
Downing HJ, Pirmohamed M, Beresford MW, Smyth RL (2013) Paediatric use of mycophenolate mofetil. Br J Clin Pharmacol 75:45–59. https://doi.org/10.1111/j.1365-2125.2012.04305.x
Article CAS PubMed Google Scholar
Filbin MG, Tirosh I, Hovestadt V, Shaw ML, Escalante LE, Mathewson ND et al (2018) Developmental and oncogenic programs in H3K27M gliomas dissected by single-cell RNA-seq. Science 360:331–335. https://doi.org/10.1126/science.aao4750
Article CAS PubMed PubMed Central Google Scholar
Gaffo AL (2014) Crystal diseases. In: McManus LM, Mitchell RN (eds) Pathobiology of human disease. Academic Press, San Diego, pp 251–306
Gandolfo MT, Jang HR, Bagnasco SM, Ko GJ, Agreda P, Soloski MJ et al (2010) Mycophenolate mofetil modifies kidney tubular injury and Foxp3+ regulatory T cell trafficking during recovery from experimental ischemia-reperfusion. Transpl Immunol 23:45–52. https://doi.org/10.1016/j.trim.2010.04.002
Article CAS PubMed PubMed Central Google Scholar
Grasso CS, Tang Y, Truffaux N, Berlow NE, Liu L, Debily MA et al (2015) Functionally defined therapeutic targets in diffuse intrinsic pontine glioma. Nat Med 21:555–559. https://doi.org/10.1038/nm.3855
Article CAS PubMed PubMed Central Google Scholar
Hashizume R, Andor N, Ihara Y, Lerner R, Gan H, Chen X et al (2014) Pharmacologic inhibition of histone demethylation as a therapy for pediatric brainstem glioma. Nat Med 20:1394–1396. https://doi.org/10.1038/nm.3716
Article CAS PubMed PubMed Central Google Scholar
Hoffman LM, Veldhuijzen van Zanten SEM, Colditz N, Baugh J, Chaney B, Hoffmann M et al (2018) Clinical, radiologic, pathologic, and molecular characteristics of long-term survivors of diffuse intrinsic pontine glioma (DIPG): a collaborative report from the international and european society for pediatric oncology DIPG registries. J Clin Oncol 36:1963–1972. https://doi.org/10.1200/JCO.2017.75.9308
Article CAS PubMed PubMed Central Google Scholar
Katagi H, Louis N, Unruh D, Sasaki T, He X, Zhang A et al (2019) Radiosensitization by histone H3 demethylase inhibition in diffuse intrinsic pontine glioma. Clin Cancer Res 25:5572–5583. https://doi.org/10.1158/1078-0432.Ccr-18-3890
Article CAS PubMed PubMed Central Google Scholar
Katagi H, Takata N, Aoi Y, Zhang Y, Rendleman EJ, Blyth GT et al (2021) Therapeutic targeting of transcriptional elongation in diffuse intrinsic pontine glioma. Neuro Oncol 23:1348–1359. https://doi.org/10.1093/neuonc/noab009
Article CAS PubMed PubMed Central Google Scholar
Khuong-Quang DA, Buczkowicz P, Rakopoulos P, Liu XY, Fontebasso AM, Bouffet E et al (2012) K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas. Acta Neuropathol 124:439–447. https://doi.org/10.1007/s00401-012-0998-0
Article CAS PubMed PubMed Central Google Scholar
Kofuji S, Hirayama A, Eberhardt AO, Kawaguchi R, Sugiura Y, Sampetrean O et al (2019) IMP dehydrogenase-2 drives aberrant nucleolar activity and promotes tumorigenesis in glioblastoma. Nat Cell Biol 21:1003–1014. https://doi.org/10.1038/s41556-019-0363-9
Article CAS PubMed PubMed Central Google Scholar
Li B, Dewey CN (2011) RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinform 12:323. https://doi.org/10.1186/1471-2105-12-323
Lin GL, Wilson KM, Ceribelli M, Stanton BZ, Woo PJ, Kreimer S et al (2019) Therapeutic strategies for diffuse midline glioma from high-throughput combination drug screening. Sci Transl Med. https://doi.org/10.1126/scitranslmed.aaw0064
Article PubMed PubMed Central Google Scholar
Mackay A, Burford A, Carvalho D, Izquierdo E, Fazal-Salom J, Taylor KR et al (2017) Integrated molecular meta-analysis of 1,000 pediatric high-grade and diffuse intrinsic pontine glioma. Cancer Cell 32(520–37):e5.
留言 (0)